Acción OSIRIS THERAPEUTICS, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas Osiris Therapeutics, Inc.

Acciones

US68827R1086

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc
WeissLaw LLP Investigates Osiris Therapeutics, Inc.
Johnson & Johnson : Smith & Nephew to buy Osiris in regenerative products push
Osiris Therapeutics : Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc.
Osiris Therapeutics, Inc. Enters Agreement to be Acquired by Smith & Nephew plc
Hagens Berman: Notice to Osiris Therapeutics, Inc. Investors: Less than One Week Left to File Claims to Receive Part of $18.5 Million Settlement
Osiris Therapeutics : Hagens Berman Notifies Osiris Therapeutics, Inc. Investors of Class Action Settlement and January 30, 2019 Claims Deadline
Osiris Therapeutics, Inc. Appoints Samson Tom, PhD, MBA to Serve as President and Chief Executive Officer
Osiris Therapeutics, Inc Reports Third Quarter 2018 Results
Osiris Appoints Willi Miesch to its Board of Directors, Change in CEO
Osiris Therapeutics, Inc. Announces Resolution of SEC Investigation
Osiris Therapeutics, Inc. Provides Update on Audit of 2015 and 2016 Financial Statements
Osiris Announces a Peer-Reviewed Publication of a Scientific Study Reporting Antimicrobial Properties of Human Cryopreserved Viable Amniotic Membrane
Osiris Therapeutics to Present 10 Advanced Clinical and Scientific Abstracts, Including an Exclusive Oral Presentation on its New Ambient Viable Tissue Preservation Technology
Osiris Announces a Peer-Reviewed Publication Reporting the Use of Placental Membranes for Refractory Cutaneous Sinus Tracts of Surgical Origin
Osiris Appoints Linda Palczuk to serve as its President & CEO
Osiris Announces Electronically Available Case Study in a Peer-Reviewed Journal:  Open Surgical Implantation of a Viable Cryopreserved Placental Membrane after Decompression and Neurolysis of Common Peroneal Nerve
Osiris Announces Scientific Manuscript Comparing Impact of Preservation Methods on Tissue Integrity and Functionality is Available Electronically in Peer-Reviewed Journal
Osiris Therapeutics to Present 29 Advanced Clinical and Scientific Abstracts, Including a Late-Breaking Abstract on its New Ambient Viable Tissue Preservation Technology
Osiris Therapeutics Announces Change in its Board of Directors
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción
  4. Noticias Osiris Therapeutics, Inc.
  5. Otros idiomas